Dr. Sara Greenhill has a brand new weapon in her arsenal to battle lung most cancers: a robotic system that’s altering the way in which sufferers are recognized and handled.
Greenhill, who joined Northwestern Drugs Palos Hospital in Palos Heights on July 1 as its first interventional pulmonologist, advocated throughout the hiring course of for a robotic-assisted bronchoscopy system for diagnosing sufferers.
“A part of the enjoyment and why I selected interventional pulmonologist is the expansion within the know-how up to now 10 to fifteen years that has been actually neat to see. To have the ability to say that I’ve been a part of that brings me pleasure,” Greenhill stated.
The know-how helps present a faster analysis, she stated, and in consequence, faster therapy and “an incredible profit to the affected person.”
Greenhill has been an interventional pulmonologist for greater than 14 years. She makes use of newer applied sciences and minimally invasive strategies to biopsy lung nodules or different plenty and lymph nodes, in addition to offering palliative therapy for superior cancers and treating sufferers who’ve power obstructive pulmonary illness, or COPD.
Greenhill, who had expertise with the brand new system, carried out the primary process on the Palos Heights hospital in late October. “There have been lots of people — everybody needed to be a part of the brand new factor,” she stated. Transferring ahead, she expects to make use of it two to 5 occasions every week.
Nothing surprising occurred throughout the process, however as a result of it was the hospital’s first, it took slightly extra time than normal.
“I’ll say that the nodule or spot I used to be making an attempt to diagnose was in a bit extra of a tough location to succeed in. However this know-how allowed me to get there whereas with one other (methodology) I might not have been in a position to do it,” she stated. “It labored properly.”
The system makes use of a small, bendable catheter that may curve and go into airways a lot smaller than conventional bronchoscopes.
Robotic-assisted bronchoscopy is used on a affected person who has an irregular nodule or spot on their lung which may be cancerous. A specialised format of the affected person’s CT scan is uploaded into its software program program.
“Doing the robotic bronchoscopy offers us the next probability of with the ability to get an correct analysis of that nodule, and in the identical setting we are able to additionally biopsy any lymph nodes or every other findings which are regarding to stage these potential lung cancers,” she defined.
“After we discover that we’re on the location, we are able to biopsy the nodule after which that can be confirmed by the pathologist on website,” she added. The workforce can depart a tiny piece of gold or titanium behind to mark that spot “and the radiation oncologist can use it to information the radiation.” The system additionally permits the spot to be tagged with dye so surgeons can see it.
Though all sufferers will profit from the brand new system, usually it should profit sufferers with earlier levels of most cancers probably the most, Greenhill stated, including that it will likely be in a position to biopsy the spot and “show or disprove” that the most cancers has not unfold.
Lung most cancers is the main reason behind most cancers deaths in the US, in line with a information launch from Northwestern Drugs, and November is Lung Most cancers Consciousness Month.
Dr. Andrew Arndt, a thoracic surgeon at Northwestern Drugs, is happy about Northwestern Drugs Palos’ new interventional pulmonology program and its superior diagnostic instruments corresponding to robotic-assisted bronchoscopy.
“These procedures assist streamline the administration of early stage lung most cancers sufferers, shifting from preliminary detection to curative-intent therapy — together with minimally invasive surgical procedure — as expeditiously as doable,” he stated. It “provides one other space of experience within the multidisciplinary care of lung most cancers sufferers.”
“The largest good thing about the IP program for sufferers going through a lung most cancers analysis is that it’s going to streamline analysis and therapy,” Arndt stated, noting it “will result in analysis and staging on the identical day, supplanting the standard mannequin with which sufferers could be extra acquainted — separate visits for biopsy and staging procedures separated by house and time.”
Day by day Southtown
Information updates from the south suburbs delivered each Monday and Wednesday
A faster path to therapy, he stated, will result in higher outcomes.
“As increasingly more knowledge present the good thing about minimizing delays in therapy for lung most cancers sufferers, the brand new IP program as a part of the general multidisciplinary collaboration will assist treatment extra lung cancers,” Arndt stated.
Greenhill shares Arndt’s purpose to supply state-of-the-art lung most cancers look after sufferers “immediately.”
“If somebody is going through most cancers or a analysis with most cancers, there are such a lot of emotions that go together with that,” she stated. “You wish to know that the affected person themselves is getting that therapy and never ready and ready — to get that analysis before later and to get them to the doctor who will handle it from there.”
Melinda Moore is a contract reporter for the Day by day Southtown.